Myelodysplastic Syndromes Clinical Trials
Myelodysplastic Syndromes clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for myelodysplastic Syndromes. Corterve aggregates actively recruiting Myelodysplastic Syndromes studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Myelodysplastic Syndromes studies
- Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative NeoplasmsNCT06303193PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell TransplantationNCT06529731PHASE2Sawa Ito, MDSt Louis, Missouri
- Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantNCT04898790NAUniversity of NebraskaOmaha, Nebraska
- Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDSNCT05350748National Cancer Institute (NCI)Bethesda, Maryland
- Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)NCT05483010PHASE2Washington University School of MedicineSt Louis, Missouri
- Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid MalignanciesNCT05588154National Cancer Institute (NCI)Bethesda, Maryland
- Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic SyndromesNCT06923488PHASE1, PHASE2West Virginia UniversityMorgantown, West Virginia
- Shwachman-Diamond Syndrome Global Patient Survey and Partnering PlatformNCT06999954Shwachman-Diamond Syndrome Alliance IncWoburn, Massachusetts
- ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid MalignanciesNCT06656494PHASE1Beijing InnoCare Pharma Tech Co., Ltd.New Haven, Connecticut
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesNCT03802695PHASE1Orca Biosystems, Inc.Duarte, California
- Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition VariantsNCT07019155National Cancer Institute (NCI)Bethesda, Maryland
- Home Blood TransfusionsNCT07121140NAThomas Jefferson UniversityPhiladelphia, Pennsylvania
Myelodysplastic Syndromes trials by state
Myelodysplastic Syndromes trials by metro
Frequently asked questions
- How do I find recruiting Myelodysplastic Syndromes clinical trials?
- Corterve aggregates actively recruiting Myelodysplastic Syndromes studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Myelodysplastic Syndromes clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Myelodysplastic Syndromes clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.